门诊子宫内膜吸引术:不明位置妊娠替代甲氨蝶呤的选择
本研究回顾性分析14,505个自体新鲜和冻融体外受精周期中110例不明位置妊娠患者,采用Karman套管门诊子宫内膜取样方案诊断妊娠位置。46例(42%)诊断为失败宫内妊娠,64例(58%)诊断为异位妊娠,失败宫内妊娠组取样后β-hCG下降至阴性的时间显著短于异位妊娠组(12.6天 vs 26.3天,P<.001)。
要点
- 不明位置妊娠伴β-hCG异常趋势者,门诊子宫内膜取样可诊断妊娠位置并避免甲氨蝶呤暴露。
- 取样后β-hCG 24小时内下降≥15%和/或病理见绒毛诊断为失败宫内妊娠,否则诊断为异位妊娠。
- 失败宫内妊娠组取样后β-hCG转阴时间显著短于异位妊娠组(12.6天 vs 26.3天,P<.001)。
核心结论
- 采用Karman套管门诊子宫内膜吸引术这一安全有效的方案,可使大部分不明位置妊娠女性免于甲氨蝶呤治疗,且妊娠消退时间短于接受甲氨蝶呤者。
研究设计与样本
- 回顾性队列研究,纳入2007年10月至2015年9月共14,505个自体新鲜和冻融体外受精周期,其中110例诊断为不明位置妊娠。
- 不明位置妊娠定义为β-hCG阳性但超声未见宫内或异位妊娠证据,且β-hCG趋势异常(2天内上升<53%或下降<15%)。
- 110例患者均接受Karman套管门诊子宫内膜取样。
主要发现
- 110例中失败宫内妊娠46例(42%),异位妊娠64例(58%)。
- 新鲜或冻融胚胎移植、移植日、取样时血清β-hCG、子宫内膜厚度及附件包块 presence 在失败宫内妊娠与异位妊娠患者间无显著差异。
- 失败宫内妊娠患者取样后β-hCG均出现充分下降(100%),但病理仅46%(n=21例)见绒毛。
- 失败宫内妊娠组取样后β-hCG转阴时间显著短于异位妊娠组(12.6天 vs 26.3天,P<.001)。
关键数值与推荐
- 取样后24小时内β-hCG下降≥15%和/或病理见绒毛诊断为失败宫内妊娠,随后每周监测β-hCG。
- β-hCG下降<15%且未见绒毛诊断为异位妊娠,接受肌内注射甲氨蝶呤(50 mg/m2)或腹腔镜治疗。
临床怎么用
- 对于体外受精后不明位置妊娠且β-hCG趋势异常者,可采用Karman套管门诊子宫内膜取样方案诊断妊娠位置,使大部分患者免于甲氨蝶呤。
- 取样后根据β-hCG下降幅度和病理绒毛结果区分失败宫内妊娠与异位妊娠,并据此管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pregnancies of unknown location with abnormal beta-human chorionic gonadotropin trends are frequently treated as presumed ectopic pregnancies with methotrexate. Preliminary data suggest that outpatient endometrial aspiration may be an effective tool to diagnose pregnancy location, while also sparing women exposure to methotrexate. OBJECTIVE: The purpose of this study was to evaluate the utility of an endometrial sampling protocol for the diagnosis of pregnancies of unknown location after in vitro fertilization. STUDY DESIGN: A retrospective cohort study of 14,505 autologous fresh and frozen in vitro fertilization cycles from October 2007 to September 2015 was performed; 110 patients were diagnosed with pregnancy of unknown location, defined as a positive beta-human chorionic gonadotropin without ultrasound evidence of intrauterine or ectopic pregnancy and an abnormal beta-human chorionic gonadotropin trend (<53% rise or <15% fall in 2 days). These patients underwent outpatient endometrial sampling with Karman cannula aspiration. Patients with a beta-human chorionic gonadotropin decline ≥15% within 24 hours of sampling and/or villi detected on pathologic analysis were diagnosed with failing intrauterine pregnancy and had weekly beta-human chorionic gonadotropin measurements thereafter. Those patients with beta-human chorionic gonadotropin declines <15% and no villi identified were diagnosed with ectopic pregnancy and treated with intramuscular methotrexate (50 mg/m2) or laparoscopy. RESULTS: Across 8 years of follow up, among women with pregnancy of unknown location, failed intrauterine pregnancy was diagnosed in 46 patients (42%), and ectopic pregnancy was diagnosed in 64 patients (58%). Clinical variables that included fresh or frozen embryo transfer, day of embryo transfer, serum beta-human chorionic gonadotropin at the time of sampling, endometrial thickness, and presence of an adnexal mass were not significantly different between patients with failed intrauterine pregnancy or ectopic pregnancy. In patients with failed intrauterine pregnancy, 100% demonstrated adequate postsampling beta-human chorionic gonadotropin declines; villi were identified in just 46% (n=21 patients). Patients with failed intrauterine pregnancy had significantly shorter time to resolution (negative serum beta-human chorionic gonadotropin) after sampling compared with patients with ectopic pregnancy (12.6 vs 26.3 days; P<.001). CONCLUSION: With the use of this safe and effective protocol of endometrial aspiration with Karman cannula, a large proportion of women with pregnancy of unknown location are spared methotrexate, with a shorter time to pregnancy resolution than those who receive methotrexate.
引用
- Insogna IG, Farland LV, Missmer SA, et al. Outpatient endometrial aspiration: an alternative to methotrexate for pregnancy of unknown location. Am J Obstet Gynecol. 2017. PMID: 28433735. doi:10.1016/j.ajog.2017.04.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。